The continuously evolving phenotype of succinic semialdehyde dehydrogenase deficiency
Journal of Inherited Metabolic Disease · 2024
DOI: 10.1002/jimd.12723 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2024. Verfasst von Natalia Alexandra Julia-Palacios und 21 weiteren Autor:innen. Beteiligte Einrichtung: Inborn Errors of Metabolism Unit, Department of Neurology, Institut de Recerca Sant Joan de Déu and CIBERER-ISCIII, Barcelona, Spain. Hauptthemen laut MEDLINE: Succinate-Semialdehyde Dehydrogenase, Phenotype, Amino Acid Metabolism, Inborn Errors. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, Medical Faculty of the Ruprecht Karl University of Heidelberg, Dietmar Hopp Foundation.
Abstract (Originalsprache)
The objective of the study is to evaluate the evolving phenotype and genetic spectrum of patients with succinic semialdehyde dehydrogenase deficiency (SSADHD) in long‐term follow‐up. Longitudinal clinical and biochemical data of 22 pediatric and 9 adult individuals with SSADHD from the patient registry of the International Working Group on Neurotransmitter related Disorders (iNTD) were studied with in silico analyses, pathogenicity scores and molecular modeling of ALDH5A1 variants. Leading initial symptoms, with onset in infancy, were developmental delay and hypotonia. Year of birth and specific initial symptoms influenced the diagnostic delay. Clinical phenotype of 26 individuals (median 12 years, range 1.8–33.4 years) showed a diversifying course in follow‐up: 77% behavioral problems, 76% coordination problems, 73% speech disorders, 58% epileptic seizures and 40% movement disorders. After ataxia, dystonia (19%), chorea (11%) and hypokinesia (15%) were the most frequent movement disorders. Involvement of the dentate nucleus in brain imaging was observed together with movement disorders or coordination problems. Short attention span (78.6%) and distractibility (71.4%) were the most frequently behavior traits mentioned by parents while impulsiveness, problems communicating wishes or needs and compulsive behavior were addressed as strongly interfering with family life. Treatment was mainly aimed to control epileptic seizures and psychiatric symptoms. Four new pathogenic variants were identified. In silico scoring system, protein activity and pathogenicity score revealed a high correlation. A genotype/phenotype correlation was not observed, even in siblings. This study presents the diversifying characteristics of disease phenotype during the disease course, highlighting movement disorders, widens the knowledge on the genotypic spectrum of SSADHD and emphasizes a reliable application of in silico approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inborn Errors of Metabolism Unit, Department of Neurology, Institut de Recerca Sant Joan de Déu and CIBERER-ISCIII, Barcelona, Spain.
- Center for Pediatric and Adolescent Medicine Department I, Division of Pediatric Neurology and Metabolic Medicine, Heidelberg University, Medical Faculty Heidelberg, Heidelberg, Germany.
- Bioinfomatics and Medical Statistics Group, University of Vic-Central University of Catalonia, Vic, Spain.
- First Department of Pediatrics, Aghia Sofia Hospital, University of Athens, Athens, Greece.
- Division of Biochemical Genetics, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
- St. Josef-Hospital, University Children's Hospital, Ruhr-University Bochum, Bochum, Germany.
ORCID-Profile: Natalia Alexandra Julia-Palacios, Oya Kuseyri Hübschmann, Mireia Olivella, Roser Pons, Gabriella Horvath, Cheuk-Wing Fung, Elisenda Cortès-Saladelafont, Saadet Mercimek-Andrews, Birgit Assmann, Filippo Manti, Heiko Brennenstuhl, Sabine Jung-Klawitter, H Serap Sivri, Sven F Garbade, Thomas Opladen
Förderung
- Instituto de Salud Carlos III
- Medical Faculty of the Ruprecht Karl University of Heidelberg
- Dietmar Hopp Foundation
- German SSADH-Defizit e.V
- De Neu. Asociación de Enfermedades de Los Neurotransmisores
Zitieren
APA
Julia-Palacios, N. A., Kuseyri Hübschmann, O., Olivella, M., Pons, R., Horvath, G., Lücke, T., Fung, C. W., Wong, S. N., Cortès-Saladelafont, E., Rovira-Remisa, M. M., Yıldız, Y., Mercimek-Andrews, S., Assmann, B., Stevanović, G., Manti, F., Brennenstuhl, H., Jung-Klawitter, S., Jeltsch, K., Sivri, H. S., …, & Opladen, T. (2024). The continuously evolving phenotype of succinic semialdehyde dehydrogenase deficiency. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12723
Vancouver
Julia-Palacios NA, Kuseyri Hübschmann O, Olivella M, Pons R, Horvath G, Lücke T, et al. The continuously evolving phenotype of succinic semialdehyde dehydrogenase deficiency. Journal of Inherited Metabolic Disease. 2024. doi:10.1002/jimd.12723
BibTeX
@article{JuliaPalacios2024,
author = {Julia-Palacios, Natalia Alexandra and Kuseyri Hübschmann, Oya and Olivella, Mireia and Pons, Roser and Horvath, Gabriella and Lücke, Thomas and Fung, Cheuk-Wing and Wong, Suet-Na and Cortès-Saladelafont, Elisenda and Rovira-Remisa, M Mar and Yıldız, Yılmaz and Mercimek-Andrews, Saadet and Assmann, Birgit and Stevanović, Galina and Manti, Filippo and Brennenstuhl, Heiko and Jung-Klawitter, Sabine and Jeltsch, Kathrin and Sivri, H Serap and Garbade, Sven F and García-Cazorla, Àngels and Opladen, Thomas},
title = {The continuously evolving phenotype of succinic semialdehyde dehydrogenase deficiency},
journal = {Journal of Inherited Metabolic Disease},
year = {2024},
doi = {10.1002/jimd.12723}
}
EUVIMED